Author

Alba Garrote-de-Barros

Universidad Complutense de MadridORCID 0009-0005-1151-9566Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Andrés Arroyo-Barea· 1 shared Irene Bragado-GarcíaiD· 1 shared Joaquín Martínez‐LópeziD· 1 shared Juan Pérez‐FernándeziD· 1 shared María Hernández‐SáncheziD· 1 shared María LinaresiD· 1 shared María Velasco‐EsteveziD· 1 shared Raquel Ancos-PintadoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrés Arroyo-Barea

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 18, 2026

MYC overexpression drives poor prognosis and differential sensitivity to treatments according to TP53 status in chronic lymphocytic leukemia

Alba Garrote-de-Barros, Juan Pérez‐Fernández, Andrés Arroyo-Barea…·María Hernández‐Sánchez

This study shows that MYC overexpression in CLL worsens prognosis and treatment response, with different effects based on TP53 status.

DOI 10.64898/2026.05.14.724995

humanbulk RNA-seq

𝕏 PostBluesky